2seventy bio, Inc.
NASDAQ:TSVT
4.99 (USD) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 71.244 | 74.958 | 71.032 | 130.414 | -127.603 | -133.575 |
| Short Term Investments
| 103.51 | 142.031 | 195.238 | 134.643 | 0 | 0 |
| Cash and Short Term Investments
| 174.754 | 216.989 | 266.27 | 362.181 | -127.603 | -133.575 |
| Net Receivables
| 0 | 13.411 | 20.96 | 16.995 | 10.691 | 7.426 |
| Inventory
| 0 | 0 | 13.638 | -114.119 | 127.603 | 133.575 |
| Other Current Assets
| 0 | 7.365 | 13.652 | 9.512 | 14.413 | 13.416 |
| Total Current Assets
| 187.256 | 237.765 | 300.882 | 291.564 | 25.104 | 20.842 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 238.15 | 278.108 | 296.62 | 310.447 | 260.481 | 257.521 |
| Goodwill
| 0 | 0 | 12.056 | 12.056 | 13.128 | 13.128 |
| Intangible Assets
| 5.885 | 6.594 | 7.302 | 9.892 | 5.644 | 9.406 |
| Goodwill and Intangible Assets
| 5.885 | 6.594 | 19.358 | 21.948 | 18.772 | 22.534 |
| Long Term Investments
| 39.352 | 4.816 | 1.414 | 97.124 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 8.867 | 38.143 | 38.391 | 38.592 | 8.263 | 14.052 |
| Total Non-Current Assets
| 292.254 | 327.661 | 355.783 | 468.111 | 287.516 | 294.107 |
| Total Assets
| 479.51 | 565.426 | 656.665 | 759.675 | 312.62 | 314.949 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.055 | 6.028 | 7.208 | 6.024 | 7.152 | 20.389 |
| Short Term Debt
| 0 | 26.437 | 22.328 | 19.538 | 30.626 | 22.634 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 15.403 | 3 | 5 | 0.82 | 8.474 |
| Other Current Liabilities
| 39.037 | 25.688 | 47.258 | 67.826 | 28.034 | 41.52 |
| Total Current Liabilities
| 40.092 | 59.779 | 79.794 | 98.388 | 75.868 | 103.397 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 244.013 | 259.008 | 544.892 | 224.58 | 244.516 |
| Deferred Revenue Non-Current
| 0 | 3.918 | 5 | 25.762 | 25.762 | 9.791 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 228.612 | 2.416 | 2.397 | -269.189 | -62.457 | -76.656 |
| Total Non-Current Liabilities
| 228.612 | 250.347 | 266.405 | 301.465 | 162.123 | 167.86 |
| Total Liabilities
| 268.704 | 310.126 | 346.199 | 399.853 | 237.991 | 271.257 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.005 | 0.005 | 0.004 | 0.002 | 74.629 | 43.692 |
| Retained Earnings
| -568.464 | -511.217 | -293.647 | -39.494 | 0 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0.089 | -0.204 | -2.877 | -0.712 | 74.629 | 43.692 |
| Other Total Stockholders Equity
| 779.176 | 766.716 | 606.986 | 400.026 | -74.629 | -43.692 |
| Total Shareholders Equity
| 210.806 | 255.3 | 310.466 | 359.822 | 74.629 | 43.692 |
| Total Equity
| 210.806 | 255.3 | 310.466 | 359.822 | 74.629 | 43.692 |
| Total Liabilities & Shareholders Equity
| 479.51 | 565.426 | 656.665 | 759.675 | 312.62 | 314.949 |